early revenue MSB, page-11

Over the next couple of yrs this move by Japan [the worlds #2 health care market], to embrace early stage approvals for cell based therapies, which are able to show safety and some measure of efficacy, will have global implications. It's human nature, if "Billy" can get a cell based treatment for something otherwise difficult to treat, "Johnny", "Susie", "Bobbie" and everybody else will "want one too"   and remember, contrary to what many believe, the USFDA are on the verge, of initiating a newgen approach to clinical trials, with the first to launch for brain cancer, here in Oz, next yr, so their thinking is not massively far away from streamlined approvals themselves! Also, I personally expect Obama to go all-out on regen medicine in his last 12mths in office....2016 very exciting!